However, if high AKT1 translates into increased Akt activation throughout the duration of chemotherapy, chronic Akt activation may promote senescence and apoptosis by downregulating MDM2 and increasing p53 in breast cancers with preserved p53 function [25, 26]. This evidence concerns the gene MDM2 and breast carcinoma.